CD2 and acute promyelocytic leukemia: However, WBC counts before treatment in the CD2+ APL group were significantly higher than in the CD2− APL group ([15.06 ± 22.49] × 109/L versus [34.97 ± 57.6] × 109/L; P = 0.028).